Jiménez-Jiménez F J, Molina J A, Vargas C, Gómez P, Navarro J A, Benito-León J, Ortí-Pareja M, Gasalla T, Cisneros E, Arenas J
Department of Neurology, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, Spain.
J Neurol Sci. 1996 Sep 15;141(1-2):39-44. doi: 10.1016/0022-510x(96)00115-3.
We measured the CSF and plasma levels of glutamate, glutamine, aspartate (only in plasma), asparagine, glutamine, glycine and GABA in 31 patients with Parkinson's disease and in 45 matched controls. We used an ion-exchange chromatography method. When compared to controls, PD patients had similar CSF levels of glutamate, glutamine, asparagine, and glycine higher CSF GABA levels higher plasma levels of glutamine, asparagine, and glycine, and lower plasma levels of aspartate. The CSF levels of the amino acids measured were not correlated with the clinical features of PD. Our results that CSF GABA levels are not decreased in PD as previously suggested.
我们测量了31例帕金森病患者和45例匹配对照者脑脊液和血浆中谷氨酸、谷氨酰胺、天冬氨酸(仅血浆中)、天冬酰胺、谷氨酰胺、甘氨酸和γ-氨基丁酸的水平。我们采用离子交换色谱法。与对照组相比,帕金森病患者脑脊液中谷氨酸、谷氨酰胺、天冬酰胺和甘氨酸水平相似,脑脊液γ-氨基丁酸水平较高,血浆中谷氨酰胺、天冬酰胺和甘氨酸水平较高,而血浆中天冬氨酸水平较低。所测氨基酸的脑脊液水平与帕金森病的临床特征无关。我们的结果表明,帕金森病患者脑脊液γ-氨基丁酸水平并未如先前所认为的那样降低。